CymitQuimica logo
CCR

CCR

Los receptores de quimiocinas C-C (CCRs) son un grupo de GPCR que responden a las quimiocinas, moléculas de señalización que guían la migración de células inmunitarias hacia sitios de inflamación o infección. Los CCR desempeñan un papel crucial en las respuestas inmunitarias, la inflamación y el desarrollo de diversas enfermedades, incluidas las enfermedades autoinmunes y el cáncer. La modulación de la actividad de los CCR se está explorando como una estrategia terapéutica para afecciones como la artritis reumatoide, la esclerosis múltiple y la infección por VIH. En CymitQuimica, ofrecemos una gama de moduladores de CCR de alta calidad para apoyar su investigación en inmunología, inflamación y desarrollo terapéutico.

Se han encontrado 166 productos para "CCR".

productos por página.
  • Denikitug


    Denikitug (GS-1811) is an Fc-optimized humanized anti-CCR8 antibody that can bind human CCR8 and antagonize CCL1 signaling, and induces NK-dependent ADCC against CCR8-high-expressing cells, facilitating tumor immunology research centered on Tregs.
    Pureza:95%
    Forma y color:Odour Liquid
    Peso molecular:~148 kDa
  • Tivumecirnon

    CAS:
    Tivumecirnon (FLX475) is a selective and oral CCR4 antagonist inhibits the infiltration and migration of Treg into the tumour microenvironment, antitumour
    Fórmula:C24H27Cl2F3N6O
    Pureza:99.88%
    Forma y color:Solid
    Peso molecular:543.41
  • Nebokitug


    Nebokitug is a humanized IgG1κ antibody targeting CCL24, with HumanIgG1kappa, Isotype Control serving as its corresponding isotype control.
    Forma y color:Odour Liquid
  • Lanerkitug


    Lanerkitug (BAY3375968) is a fully humanized anti-CCR8 IgG1 mAb that depletes CCR8+ Tregs via ADCC and ADCP, with potential in solid tumor therapy.
    Pureza:95%
    Forma y color:Odour Liquid
    Peso molecular:~148 kDa
  • Enzelkitug

    CAS:
    Enzelkitug is a humanized IgG1-κ monoclonal antibody targeting CCR8 that blocks CCR8 signaling and modulates the tumor immune microenvironment.
    Peso molecular:~150 kDa
  • Cafelkibart


    Cafelkibart is a chimeric IgG1κ monoclonal antibody targeting CCR8, with HumanIgG1kappa, Isotype Control serving as its corresponding isotype control.
    Forma y color:Odour Liquid
  • MLN3126

    CAS:
    MLN3126: Oral CCR9 blocker, hinders CCL25-triggered chemotaxis/thymocyte calcium influx, IC50 of 6.3 nM.
    Fórmula:C21H19ClN2O5S
    Forma y color:Solid
    Peso molecular:446.904
  • S-531011


    S-531011 is a human IgG1 monoclonal antibody that targets CCR8. It reduces tumor-infiltrating CCR8+ Tregs and exhibits antitumor activity in CT26.WT and EMT6 tumor-bearing mouse models. S-531011 is useful for cancer immunotherapy research. The recommended isotype control is HumanIgG1kappa, Isotype Control.
  • AT008


    AT008 is a monoclonal antibody that targets GPCR and inhibits the binding of chemokine ligands to their cell surface receptor, CCR4. [AT008] is applicable in the study of certain hematological cancers and solid tumors.
  • Anti-Human CCR8 Antibody (10A11)


    Anti-CCR8 Antibody (10A11) is a humanized IgG1 monoclonal antibody targeting CCR8.
  • HGS004


    HGS004 is a humanized IgG4 monoclonal antibody inhibitor targeting CCR5. It exhibits potent antiviral activity against various CCR5-tropic HIV-1 strains, including those resistant to other treatments (such as Maraviroc-resistant strains). HGS004 is applicable for research in HIV-1 infection.
    Forma y color:Odour Liquid
  • CCR1 antagonist 7

    CAS:
    CCR1 antagonist 7 (compound 16r) is an antagonist of chemokine receptor 1 (CCR1) with an IC 50 of 4 nM [1].
    Fórmula:C21H24ClN5O3S
    Pureza:98%
    Forma y color:Solid
    Peso molecular:461.96
  • BMS-457

    CAS:
    BMS-457 is a potent, CCR1-selective antagonist.
    Fórmula:C24H35ClN2O4
    Pureza:98%
    Forma y color:Solid
    Peso molecular:451
  • JNJ-27141491

    CAS:
    JNJ-27141491 is a potent, noncompetitive antagonist of human CCR2.
    Fórmula:C17H15F2N3O3S
    Pureza:98%
    Forma y color:Solid
    Peso molecular:379.38
  • TAK-220

    CAS:
    TAK-220: Oral CCR5 antagonist. IC50: 3.5 nM (RANTES), 1.4 nM (MIP-1α).
    Fórmula:C31H41ClN4O3
    Pureza:98%
    Forma y color:Solid
    Peso molecular:553.135
  • AZD-1678

    CAS:
    AZD-1678 is a potent CCR4 receptor antagonist.
    Fórmula:C11H8Cl2FN3O3S
    Forma y color:Solid
    Peso molecular:352.17
  • ALK4290

    CAS:
    ALK4290 (AKST4290), a potent oral CCR3 inhibitor with a Ki of 3.2 nM, may treat macular degeneration and Parkinsonism.
    Fórmula:C27H34ClN5O3
    Forma y color:Solid
    Peso molecular:512.044
  • RPT193

    CAS:
    RPT193 is an oral CCR4 inhibitor reducing Th2 cell migration in atopic dermatitis, asthma, and allergies.
    Fórmula:C27H34Cl3N5O2
    Forma y color:Solid
    Peso molecular:566.95
  • CCR2 antagonist 3

    CAS:
    CCR2 antagonist 3 (AZD-2927) is an antagonist of CCR2.
    Fórmula:C17H25FN2O2
    Pureza:99.87%
    Forma y color:Solid
    Peso molecular:308.391
  • PNU-177864 hydrochloride

    CAS:
    PNU-177864 hydrochloride is a potent, selective and orally active antagonist of dopamine D3 receptor.
    Fórmula:C18H22ClF3N2O3S
    Pureza:99.95%
    Forma y color:Solid
    Peso molecular:438.89